Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
DOI: 10.1038/s41598-019-52088-7, Coutinho, S
Primary outcome: Results Semaglutide showed robust therapeutic effects in treatment-seeking participants with obesity and alcohol use disorder and this trial supports previous preclinical and clinical findings suggesting GLP-1 receptor agonists as a potential novel treatment target for alcohol use disorder
WHAT IT IS
Mild stomach discomfort
US$ 20.07
US$ 20.69
US$ 28.28
